文献速递外周动脉疾病主动脉疾病

严重主髂动脉闭塞性疾病直接与微创技术治疗的比较

Comparison of Direct and Less Invasive Techniques for the Treatment of Severe Aorto-Iliac Occlusive Disease.
PubMed 文献 · Ann Vasc Surg · 2017-07-21

基于血管质量倡议登记的多中心回顾性队列,比较主双股/主单股旁路(ABF/AUF)与股股交叉旁路/杂交股动脉内膜剥脱联合髂动脉支架(CFB/EPS)治疗严重主髂动脉闭塞性疾病。倾向评分匹配后,ABF/AUF 1年一期通畅率优于 CFB/EPS(94.1%±1.1% vs 92.3%±1.5%,HR 0.65,95%CI 0.45-0.94,P=0.02),但术式不是1年生存或大截肢的预测因素。

要点

  • ABF/AUF 1年一期通畅率优于 CFB/EPS,HR 0.65(95%CI 0.45-0.94,P=0.02)。
  • 术式不是1年死亡或大截肢的预测因素,患者因素和手术指征影响更大。
  • 严重主髂动脉闭塞性疾病中,微创策略需权衡一期通畅率与患者风险。

核心结论

  • 在倾向匹配的多中心血管外科登记队列中,直接 approach(ABF/AUF)治疗主髂动脉闭塞性疾病1年一期通畅率优于常用微创策略(CFB/EPS)。
  • 治疗方式不是1年生存或保肢的预测因素,患者因素和手术指征对结局影响更大。

研究设计与样本

  • 回顾性队列研究,使用血管外科学会血管质量倡议登记,纳入2006至2013年因主髂动脉闭塞性疾病接受ABF/AUF或CFB/EPS的患者。
  • 共1872例患者,其中ABF/AUF 1133例,CFB/EPS 739例;倾向评分匹配后队列包括ABF/AUF 1094例和CFB/EPS 711例。
  • 采用Kaplan-Meier分析和Cox模型评估1年生存、一期通畅率和大截肢。

主要发现

  • 研究期间共1872例患者接受主髂动脉闭塞性疾病手术,其中危重肢体缺血占47.3%(n=886)。
  • 中位随访时间305天(范围10-406天)。
  • 多因素分析显示患者因素和手术指征是1年死亡和大截肢的显著预测因素,但术式不是。
  • ABF/AUF与CFB/EPS相比,1年一期通畅率提高(94.1%±1.1% vs 92.3%±1.5%,HR 0.65,95%CI 0.45-0.94;P=0.02)。

临床怎么用

  • 对于严重主髂动脉闭塞性疾病,选择直接旁路(ABF/AUF)可能获得更优的1年一期通畅率,但需结合患者因素和手术指征综合决策。
  • 微创策略(CFB/EPS)在1年生存和保肢方面与直接旁路相当,可作为高风险患者的替代选择。

局限性

  • 回顾性队列设计,可能存在选择偏倚和未测量混杂。
  • 随访时间较短(中位305天),仅报告1年结局。
  • 数据来源于登记系统,可能存在报告偏倚和信息缺失。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Severe aorto-iliac occlusive disease (AIOD) is traditionally treated with aorto-bifemoral bypass (ABF) or aorto-unifemoral bypass (AUF). However, cross-femoral bypass (CFB) and hybrid femoral endarterectomy and patch angioplasty with iliac stenting (EPS) have gained popularity as less invasive options. We sought to compare 1-year survival, primary patency, and major amputation rates between open surgical (ABF and AUF) and 2 less invasive reconstruction techniques (CFB and EPS) using a large, multicenter cohort. STUDY DESIGN: This is a retrospective cohort study of patients who underwent either ABF/AUF or CFB/EPS for AIOD between 2006 and 2013 in the Society for Vascular Surgery Vascular Quality Initiative registry. Baseline patient and periprocedural variables were compared. Propensity score matching (PSM) was performed to predict the likelihood of more invasive repair. Kaplan-Meier analysis and Cox models were performed for 1-year survival, primary patency, and major amputation. RESULTS: 1872 patients underwent procedures for AIOD, including 1,133 ABF/AUF and 739 CFB/EPS, during the study period. Indication was critical limb ischemia in 47.3% (n = 886). Median follow-up time was 305 days (range, 10-406). After PSM, the matched cohort included 1,094 ABF/AUF and 711 CFB/EPS patients. Multivariate analysis revealed that patient factors and procedure indication were significant predictors of 1-year mortality and major amputation, but not procedure type. ABF/AUF was associated with improved primary patency over CFB/EPS at 1 year (94.1% ± 1.1% vs. 92.3% ± 1.5%, hazard ratio 0.65, 95% confidence interval 0.45-0.94; P = 0.02). CONCLUSIONS: In a propensity-matched cohort from a multicenter vascular surgery registry, a direct approach to AIOD (ABF/AUF) demonstrated better 1-year primary patency than commonly used less invasive strategies. However, treatment approach was not a predictor of 1-year survival or limb salvage, suggesting that patient factors and procedure indication have a greater impact on outcome.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Zamor KC, Hoel AW, Helenowski IB, et al. Comparison of Direct and Less Invasive Techniques for the Treatment of Severe Aorto-Iliac Occlusive Disease. Ann Vasc Surg. 2017. PMID: 28739459. doi:10.1016/j.avsg.2017.07.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。